Brief: Pluristem Therapeutics Presents Data From First Cohort In Ongoing Phase I Hematological Study
03/12/2018 12:33
Dec 3 (Reuters) - Pluristem Therapeutics Inc PSTI.O :
* PLURISTEM PRESENTS DATA FROM FIRST COHORT IN ONGOING PHASE
I
HEMATOLOGICAL STUDY AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH)
ANNUAL MEETING
Source text for Eikon: ID:nGNX6q8S8R
Further company coverage: PSTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pluri
See all newsBrief: Pluri Chairman And Active Investor Alejandro Weinstein To Acquire Eib Loan, In Strong Vote Of Confidence In The Company
Brief: Ever After Foods Acquires Fishway To Expand Integrated Food Production Technology Platform
NASDAQ RESUMED AT 09:38 AM
NASDAQ RESUMED AT 09:33 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM